[1]Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. Lancet Infect Dis, 2018, 18 (3): 318-327. DOI:10.1016/S1473-3099(17)30753-3.
[2]王晓,辜依海,张微,等.碳青霉烯耐药肺炎克雷伯菌感染和死亡的相关因素分析[J].中华预防医学杂志, 2024, 58(4): 545-551. DOI:10.3760/cma.j.cn112150-20231005-00235.
[3]Lapp Z, Han JH, Wiens J, et al. Patient and microbial genomic factors associated with carbapenem-resistant klebsiella pneumoniae extraintestinal colonization and infection[J]. mSystems, 2021, 6(2): e00177-21. DOI: 10.1128/mSystems.00177-21.
[4]王夙昕,邸玥莹,邹慧青,等.厦门地区医院感染大肠埃希菌及肺炎克雷伯菌产KPC的调查研究[J].国际医药卫生导报, 2023, 11: 1514-1518. DOI: 10.3760/cma.j.issn.1007-1245.2023.11.008.
[5]Tsuchida S, Umemura H, Nakayama T. Current status of matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) in clinical diagnostic microbiology[J]. Molecules, 2020, 25 (20): 4775. DOI: 10.3390/molecules25204775.
[6]Cheon DH, Jang H, Choi YK, et al. Clinical evaluation of advanced MALDI-TOF MS for carbapenemase subtyping in Gram-negative isolates[J]. J Clin Microbiol, 2024, 63(1): e0147524. DOI:10.1128/jcm.01475-24.
[7]Gonçalves Barbosa LC, Silva E Sousa JA, Bordoni GP, et al. Elevated mortality risk from CRKP associated with comorbidities: systematic review and meta-analysis[J]. Antibiotics (Basel), 2022, 11(7): 874. DOI:10.3390/antibiotics11070874.
[8]王艳,崔佳,王丹丹,葛春悦,胡云建,艾效曼.耐碳青霉烯肺炎克雷伯菌肺炎患者共病因素与患者住院期间死亡相关因素的分析[J].中华预防医学杂志,2024,58(11):1705-1710. DOI:10.3760/cma.j.cn112150-20240612-00462.
[9]Naidoo N, Zishiri OT. Comparative genomics analysis and characterization of Shiga toxin-producing Escherichia coli O157: H7 strains reveal virulence genes, resistance genes, prophages and plasmids[J]. BMC Genomics, 2023, 24 (1): 791. DOI: 10.1186/s12864-023-09902-4.
[10]Schürch AC, Arredondo-Alonso S, Willems RJL, et al. Whole genome sequencing options for bacterial strain typing and epidemiologic analysis based on single nucleotide polymorphism versus gene-by-gene-based approaches[J]. Clin Microbiol Infect, 2018, 24 (4): 350-354. DOI:10.1016/j.cmi.2017.12.016.
[11]程国平,简雪峰,许德英,等. MALDI-TOF MS在碳青霉烯 耐药肺炎克雷伯菌流行病学分析中的应用[J].南京医科大学学报(自然科学版), 2019, 39(1): 62-66. DOI:10.7665/njmu.201901.0011.
[12]王璐,高绪锋,张凤丽,等.耐碳青霉烯肺炎克雷伯菌耐药基因检测及其同源性分析[J].蚌埠医学院学报, 2019, 44(1): 107-111. DOI: 10.13898/j.cnki.issn.1000-2200.2019.01.030.
[13]张杰,张金鑫,楚新旭,等. MALDI-TOF MS在耐碳青霉烯类肺炎克雷伯菌同源性分析的应用研究[J].中国抗生素杂志, 2022, 47(4): 381-387. DOI: 10.13461/j.cnki.cja.007138.
[14]余佳佳,刘婧娴,李媛睿,等.利用MALDI-TOF MS特异质量峰对耐碳青霉烯类肺炎克雷伯菌同源性的快速分型[J].中国感染控制杂志, 2019, 18(3): 206-212. DOI: 10.12015/j.issn.1673-4666.2019.03.002.
[15]李晓婷,詹思延.单核苷酸多态性检测技术及其应用研究进展[J].中国公共卫生, 2009, 25(2): 250-252. DOI: 10.3321/j.issn:1001-0580.2009.02.067.
[16]Busby EJ, Doyle RM, Leboreiro Babe C, et al. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for molecular typing of acinetobacter baumannii in comparison with orthogonal methods[J]. Microbiol Spectr, 2023, 11(3): e0499522. DOI:10.1128/spectrum.04995-22.
[17]段雪寒,吴华. MALDI-TOF MS技术在临床微生物检验中的应用[J].检验医学, 2024, 39(4): 410-414. DOI: 10.3969/j.issn.1673-8640.2024.04.017.
[18]Jiang F, Kong Z, Cheng C, et al. Overestimated discriminatory power of MALDI-TOF mass spectrometry for typing of carbapenem-resistant Klebsiella pneumoniae clones[J]. Epidemiol Infect, 2019, 147: e324. DOI: 10.1017/S0950268819002097.
[19]田月如,关明,李敏.MALDI-TOF MS技术在临床微生物诊断应用中的挑战[J].中华检验医学杂志,2018,41(8):559-562. DOI: 10.3760/cma.j.issn.1009-9158.2018.08.001.
[20]Sogawa K, Kiyosuke M, Hattori K, et al. Examination of conditions for regular internal quality control in identification of microorganisms using MALDI-TOF MS[J]. Biocontrol Sci, 2021, 26(2): 99-104. DOI:10.4265/bio.26.99.
[21]中华医学会检验医学分会临床微生物学组. MALDI-TOF MS鉴定病原微生物临床应用专家共识[J].中华检验医学杂志, 2024, 47(9): 1013-1026. DOI: 10.3760/cma.j.cn114452-20240218-00077.
|